Moreover, long-term tamoxifen treatment has been reported to facilitates the translocation of GPER to cell membranes, resulting in abnormal activation of the EGFR/ERK signaling pathway, which enhances communications between tumor cells and their microenvironment [85]. The gene discussed is EGFR; the disease is neoplasm.